Bringing the Trial to the Patient: Leveraging Remote Safety Monitoring to Accelerate Oncology Innovation
As oncology trials become more complex and patient-centric, remote safety monitoring is proving to be a game-changer—enabling faster enrollment, broader access, and better outcomes.
In this exclusive webinar, leaders from AbbVie, Roche, and Best Buy Health will share how they’re integrating remote monitoring into oncology trials to boost efficiency, support diverse populations, and enhance patient safety.
What You’ll Learn
- How top pharma companies are using remote monitoring in immunotherapy, CRS detection, and medication adherence
- Strategies to extend trial reach into underserved areas with decentralized models
- The growing role of AI and real-world evidence in proactive safety and trial optimization
- Practical examples you can apply to your current or upcoming oncology studies
Speakers
- Kaustav Chatterjee, MD – Medical Director, Global Medical Affairs, AbbVie
- Stephen Ranjan – Global Head of Digital Health, Roche
- Moderator: J. Cris Salinas, MD – Head of Pharma, Best Buy Health
Whether you lead clinical operations, digital health strategy, or innovation, this session will offer practical insights into how RPM can be harnessed to drive oncology therapies forward.
👉 Reserve your spot now and be part of the conversation shaping the future of decentralized oncology trials.
